SecBot SecBot

JSPRW

Jasper Therapeutics, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001788028 Biotech & Drug Discovery
Former ticker of Jasper Therapeutics, Inc. · JSPR stock page →
—
Market cap
$43.3K
Nano cap
1 year
−78.3%
from $2.33 · Oct 27
30 days
−19.3%
from $0.6260
52-week range
$0.3410–2.36
−79% from high · low Jun 26
Avg volume 20D
379.9K
shares / day
Short interest
21.0K
≈0.1% of shares · +16.4%
Days to cover
1.4
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 3 bearish · 0 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BEARISH Jasper Therapeutics received a Nasdaq deficiency notice on June 3, 2026, because its common stock bid price…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersBUILDING

    Short interest +16.4% to 21.0K shares. 1.4 days to cover, ≈0.1% of shares.

  • TrendDOWNTREND

    19% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
WOLVERINE ASSET MANAGEMENT LLCADD1,639$22.00
Walleye Capital LLCTRIM200,000$8.0K
UBS Group AGTRIM1,304$133.00
Walleye Trading LLCDOUBLED35,138$7.4K

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 25, 2026
Listing
Delisted: JSPRW — removed from the Nasdaq symbol directory
Jasper Therapeutics, Inc. - Warrant
Sep 25, 2026
Trading halt
Halt Resumed: JSPRW — trading resumed after D (Security Deletion)
Halted 2026-09-24T20:00:30.000Z | Resumed 2026-09-25T04:00:01.000Z
Sep 24, 2026
Listing
Listing Status: JSPRW — Normal (was Deficient)
Jasper Therapeutics, Inc. - Warrant | Nasdaq Financial Status Indicator D → N
Sep 24, 2026
Trading halt
Trading Halt: JSPRW — T12 (Additional Information Requested)
Jasper Therapeutics Wts | Market: NASDAQ | Code: T12 — Additional Information Requested
Sep 24, 2026
Trading halt
Trading Halt: JSPRW — D (Security Deletion)
Jasper Therapeutics Wts | Market: NASDAQ | Code: D — Security Deletion

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 15, 2026
20,996
shares short
+16.4%
vs prior settlement
1.4
days to cover
≈0.1%
of shares outstanding
Trading halts
Sep 24, 2026DeletionResumed
Jul 16, 2026Resumption ScheduledNot resumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 25, 2026 Listing status
Delisted: JSPRW — removed from the Nasdaq symbol directory
Jasper Therapeutics, Inc. - Warrant
Jun 30, 2026 Inst.
WOLVERINE ASSET MANAGEMENT LLC — ADD
1,639 shares ($22.00)
Jun 9, 2026 SEC
Jasper Therapeutics received a Nasdaq deficiency notice on June 3, 2026, because its common stock bid price closed…
8-K — Impact 7/10
Jun 1, 2026 SEC
Jasper Therapeutics announced its Board has initiated a comprehensive review of strategic alternatives to maximize…
8-K — Impact 6/10
May 21, 2026 SEC
Jasper Therapeutics disclosed the resignation of board member Christian Nolet, effective May 15, 2026, citing no…
8-K — Impact 2/10
Dec 31, 2025 Inst.
Walleye Capital LLC — TRIM
200,000 shares ($8.0K)

SecBot reports

5 filings · 0 bullish · 3 bearish · 1 mixed · 1 neutral
All JSPRW filing & press-release reports (5)